Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monthly Risedronate Dose-Ranging Study in Postmenopausal Women
NCT00577837Phase 2Completed
- Sponsor
- Warner Chilcott
- Start
- Apr 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of risedronate in osteoporosis, sponsored by Warner Chilcott. Started Apr 2004; status: completed.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00577837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00577837.